Shanghai Kehua Bio-Engineering Co.,Ltd (SHE:002022)
China flag China · Delayed Price · Currency is CNY
5.98
-0.06 (-0.99%)
Sep 29, 2026, 12:44 PM CST

SHE:002022 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Revenue
1,6921,6271,7462,4176,9164,844
Other Revenue
-5.2215.1413.2111.4754.2910.62
1,6861,6421,7592,4286,9704,854
Revenue Growth
2.56%-6.63%-27.55%-65.16%43.58%16.82%
Cost of Revenue
1,2751,2541,2471,4833,4052,208
Gross Profit
411.76388.54511.95944.723,5642,647
Selling, General & Admin
702.83731.35769.85877.111,258809.79
Research & Development
193.84189.62198.67241.36250.49148.47
Other Operating Expenses
-0.551.454.34-41.22-118.056.08
Operating Expenses
1,0491,0791,1611,0861,448978.51
Operating Income
-636.79-690.04-648.69-140.952,1171,668
Interest Expense
-23.35-23.32-42.23-43.74-40.06-40.15
Interest & Investment Income
8.068.1433.4353.9248.2626.79
Currency Exchange Gain (Loss)
-6.362.84-0.583.478.75-28.61
Other Non Operating Income (Expenses)
0.15-0.07-6.38-12.62-18.39-2.16
EBT Excluding Unusual Items
-658.29-702.45-664.44-1402,1851,624
Impairment of Goodwill
-66.21-66.21-25.51-41.82-109.6-9.79
Gain (Loss) on Sale of Investments
0.010.03-1.171.47--1.96
Gain (Loss) on Sale of Assets
2.83.874.215.024.532.06
Asset Writedown
-60.4-54.42-67.74-40.78-36.38-5.82
Other Unusual Items
14.147.0719.6930.2420.7428.9
Pretax Income
-767.94-812.11-734.85-185.612,0651,637
Income Tax Expense
71.9872.68-4.2-8.62332.96283.58
Earnings From Continuing Operations
-839.92-884.79-730.65-176.991,7321,354
Minority Interest in Earnings
137.47152.6590.05-57.03-760.66-503.41
Net Income
-702.46-732.14-640.6-234.01971.56850.41
Net Income to Common
-702.46-732.14-640.6-234.01971.56850.41
Net Income Growth
----14.25%25.92%
Shares Outstanding (Basic)
514514505514514514
Shares Outstanding (Diluted)
514514505514533532
Shares Change
1.14%1.86%-1.83%-3.55%0.27%3.75%
EPS (Basic)
-1.37-1.42-1.27-0.461.891.65
EPS (Diluted)
-1.37-1.42-1.27-0.461.821.60
EPS Growth
----13.94%21.37%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
-113.78-116.86-304.94-805.821,726863.19
Free Cash Flow Per Share
-0.22-0.23-0.60-1.573.241.62
Dividend Per Share
----0.6000.065
Dividend Growth
----823.08%-67.50%
Gross Margin
24.42%23.66%29.10%38.91%51.14%54.52%
Operating Margin
-37.76%-42.01%-36.87%-5.80%30.37%34.36%
Profit Margin
-41.65%-44.57%-36.41%-9.64%13.94%17.52%
Free Cash Flow Margin
-6.75%-7.12%-17.33%-33.19%24.76%17.78%
EBITDA
-443.44-485.45-427.5448.412,2831,796
EBITDA Margin
-26.29%-29.56%-24.30%1.99%32.75%37.01%
D&A For EBITDA
193.35204.59221.14189.36165.77128.27
EBIT
-636.79-690.04-648.69-140.952,1171,668
EBIT Margin
-37.76%-42.01%-36.87%-5.80%30.37%34.36%
Effective Tax Rate
----16.12%17.32%
Revenue as Reported
1,6861,6421,7592,4286,9704,854
Advertising Expenses
-6.8516.4730.1259.5947.01